Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
株式のランク #19935
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
株価
$5.22
時価総額
$146.14M
変化(1日)
-1.35%
変化(1年)
-32.16%
BE
取引 Hyloris Pharmaceuticals S.A. (HYL)

カテゴリー

Hyloris Pharmaceuticals S.A.(HYL)のEPS
2026 時点のEPS TTM: 0
Hyloris Pharmaceuticals S.A.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Hyloris Pharmaceuticals S.A.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH